NASDAQ:CGNT - Vision Sciences Stock Price, Price Target & More Sign in or create an account to add this stock to your watchlist. Get Started $3.85 0.00 (0.00 %) (As of 07/19/2018 03:09 PM ET)Previous Close$3.85Today's Range$3.85 - $3.8552-Week Range$1.55 - $3.92VolumeN/AAverage Volume183,912 shsMarket Capitalization$234.49 millionP/E Ratio-385.00Dividend YieldN/ABeta0.58 Company ProfileFinancialsAnalyst RatingsEarnings HistoryInsider TradesHeadlinesOptions ChainSEC FilingsSocial MediaChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Cogentix Medical, Inc., a medical device company, designs, develops, manufactures, and markets fiberoptic and video endoscopy products under the PrimeSight brand worldwide. The company offers endoscopes, such as cystoscopes, laryngoscopes, transnasal esophagoscopes, and bronchoscopes for medical use; and borescopes for industrial use, as well as digital processing units for medical use. It also provides EndoSheath Protective Barrier, a sterile, single-use microbial barrier for use with flexible endoscopes. In addition, the company offers Urgent PC System, a neuromodulation system that delivers percutaneous tibial nerve stimulation for office-based treatment of overactive bladder; and Macroplastique, an injectable, urethral bulking agent for the treatment of adult female stress urinary incontinence. Further, it provides Macroplastique products for the treatment of vesicoureteral reflux; PTQ Implants to treat fecal incontinence; Urgent PC System for the treatment of fecal incontinence; and VOX Implants to enhance speech and swallowing function in patients with unilateral vocal cord paralysis. Additionally, the company distributes wound care products in the Netherlands and the United Kingdom. Cogentix Medical, Inc. sells its products through a direct sales force and a network of distributor organizations. The company was founded in 1987 and is headquartered in Minnetonka, Minnesota. Receive CGNT News and Ratings via Email Sign-up to receive the latest news and ratings for CGNT and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Electromedical equipment Sub-IndustryN/A SectorMedical SymbolNASDAQ:CGNT CUSIPN/A Webwww.cogentixmedical.com Phone952-426-6140 Debt Debt-to-Equity RatioN/A Current Ratio4.66 Quick Ratio3.90 Price-To-Earnings Trailing P/E Ratio-385.00 Forward P/E Ratio385.00 P/E GrowthN/A Sales & Book Value Annual Sales$56.32 million Price / Sales4.16 Cash Flow$0.0392 per share Price / Cash98.24 Book Value$1.05 per share Price / Book3.67 Profitability EPS (Most Recent Fiscal Year)($0.01) Net Income$-880,000.00 Net Margins-1.57% Return on Equity-1.39% Return on Assets-1.21% Miscellaneous Employees208 Outstanding Shares60,910,000Market Cap$234.49 Vision Sciences (NASDAQ:CGNT) Frequently Asked Questions What is Vision Sciences' stock symbol? Vision Sciences trades on the NASDAQ under the ticker symbol "CGNT." How were Vision Sciences' earnings last quarter? Vision Sciences Inc. (NASDAQ:CGNT) released its quarterly earnings results on Tuesday, November, 3rd. The medical device company reported ($0.06) earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of ($0.07) by $0.01. The medical device company had revenue of $11.80 million for the quarter, compared to the consensus estimate of $11.45 million. Vision Sciences had a negative return on equity of 1.39% and a negative net margin of 1.57%. View Vision Sciences' Earnings History. What price target have analysts set for CGNT? 3 brokerages have issued 1-year target prices for Vision Sciences' stock. Their forecasts range from $4.00 to $5.00. On average, they anticipate Vision Sciences' stock price to reach $4.5833 in the next twelve months. This suggests a possible upside of 19.0% from the stock's current price. View Analyst Ratings for Vision Sciences. What is the consensus analysts' recommendation for Vision Sciences? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Vision Sciences in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." Who are some of Vision Sciences' key competitors? Some companies that are related to Vision Sciences include Viewray (VRAY), Cutera (CUTR), BioLife Solutions (BLFS), Rockwell Medical (RMTI), Helius Medical Technologies (HSDT), Fonar (FONR), Second Sight Medical Products (EYES), Zynex Inc. common stock (ZYXI), Edap Tms (EDAP), Semler Scientific (SMLR), Viveve Medical (VIVE), BioSig Technologies (BSGM), IRIDEX (IRIX), Soleno Therapeutics (SLNO) and Stereotaxis (STXS). Who are Vision Sciences' key executives? Vision Sciences' management team includes the folowing people: Mr. Darin Hammers, Pres, CEO & Director (Age 53)Mr. Brett A. Reynolds, Sr. VP, CFO & Corp. Sec. (Age 49)Mr. Chris Arnold, VP of Global Sales (Age 50)Mr. Larry Heinemann, VP of Corp. Devel. (Age 66)Mr. Ash Keswani, Sr. VP of Marketing & Bus. Devel. Has Vision Sciences been receiving favorable news coverage? News stories about CGNT stock have trended somewhat positive recently, Accern Sentiment reports. Accern rates the sentiment of media coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Vision Sciences earned a news sentiment score of 0.02 on Accern's scale. They also assigned headlines about the medical device company an impact score of 45.16 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the near term. How do I buy shares of Vision Sciences? Shares of CGNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Vision Sciences' stock price today? One share of CGNT stock can currently be purchased for approximately $3.85. How big of a company is Vision Sciences? Vision Sciences has a market capitalization of $234.49 million and generates $56.32 million in revenue each year. The medical device company earns $-880,000.00 in net income (profit) each year or ($0.01) on an earnings per share basis. Vision Sciences employs 208 workers across the globe. How can I contact Vision Sciences? Vision Sciences' mailing address is 5420 FELTL ROAD, MINNETONKA MN, 55343. The medical device company can be reached via phone at 952-426-6140 or via email at [email protected] MarketBeat Community Rating for Vision Sciences (NASDAQ CGNT)Community Ranking: 1.8 out of 5 ()Outperform Votes: 94 (Vote Outperform)Underperform Votes: 161 (Vote Underperform)Total Votes: 255MarketBeat's community ratings are surveys of what our community members think about Vision Sciences and other stocks. Vote "Outperform" if you believe CGNT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CGNT will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 7/19/2018 by MarketBeat.com StaffFeatured Article: What is a closed-end mutual fund (CEF)?